Op. Dr. Arife Esra Kocakaya | İzmir Göz Hastalıkları Uzmanı
arifeesrakocakaya.com
LaunchIndex first observed Op. Dr. Arife Esra Kocakaya | İzmir Göz Hastalıkları Uzmanı (arifeesrakocakaya.com) live on 8 November 2026. View its launch screenshot, category, technologies, and verification evidence.
A launch record built from evidence.
Op. Dr. Arife Esra Kocakaya | İzmir Göz Hastalıkları Uzmanı (arifeesrakocakaya.com) was first observed live on 8 November 2026.
Ophthalmology practice of Op. Dr. Arife Esra Kocakaya in Izmir offering cataract treatment, smart intraocular lenses, eyelid surgery, and care for keratoconus and strabismus.
Its profile is classified as Professional service within Health / Health and wellness. Verification detected WordPress.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- arifeesrakocakaya.com
- Category
- Health / Health and wellness
- Website type
- Professional service
- Observed title
- Op. Dr. Arife Esra Kocakaya | İzmir Göz Hastalıkları Uzmanı
- Observed description
- İzmir Alsancak'ta göz hastalıkları uzmanı Op. Dr. Arife Esra Kocakaya: katarakt ve akıllı mercek, göz çizdirme, göz kapağı estetiği, keratokonus ve şaşılık.
- Detected technologies
- WordPress
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
A canonical launch profile for arifeesrakocakaya.com.
Share the profile directly or add the optional badge to the website. A badge is never required for inclusion, verification, or ranking.
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.